Side-by-side comparison
ABT vs VRTX — Side-by-side comparison
ABT screens cheaper on EV/FCF, VRTX has the higher ROIC, VRTX has grown revenue faster over five years, and ABT has the cleaner balance sheet by net debt / EBITDA.
ABT
Abbott Labs
Price
$87.41
Market cap
$230.7B
Day %
N/A
VRTX
VERTEX PHARMACEUTICALS INC / MA
Price
N/A
Market cap
N/A
Day %
N/A
ABT implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
31.8x
FCF yield
3.2%
5Y rev CAGR
5.1%
VRTX implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
14.1%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for ABT.
Grade C
64
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for VRTX.
Grade D
38
/ 100
Quality Radar0 – 20 per axis